Latest News

  • Quanterix, Mobidiag, WuXi NextCODE, And More: News From December 2017

    Diagnostics World | December featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Quanterix, Mobidiag, WuXi NextCODE, and more.

    Jan 3, 2018
  • Too Much Screening Has Misled Us About Cancer Risk Factors

    STAT | Widespread screening for "scrutiny-dependent" cancers is misleading doctors and the public about what increases our risk of developing cancer.

    Jan 2, 2018
  • Top 10 Stories Of 2017: Two Pore Guys, The IVD industry Today, And More

    Diagnostics World | As we head into 2018, we at Diagnostics World would like to take a moment and reflect on the groundbreaking achievements from this past year. In that spirit, here are the top 10 stories of 2017.

    Dec 27, 2017
  • FDA Approves, CMS Proposes Coverage For Foundation Medicine’s NGS-Based Test

    Diagnostics World | Foundation Medicine’s FoundationOne CDx test recently became the second NGS-based IVD to be approved and covered after overlapping review by the FDA and CMS under the Parallel Review Program, which facilitates earlier access to innovative medical technologies for Medicare beneficiaries.

    Dec 21, 2017
  • Year In Review: 2017 Conferences, Discussions, Awards

    Diagnostics World | A look back at the conferences held by Cambridge Healthtech Institute, covering a wide range of content that focused on delivering insights on the tools, innovations, and breakthroughs that are emerging from the expanding field of diagnostics.

    Dec 19, 2017
  • Gamers Help Researchers Tackle The Problem Of Protein Folding

    Diagnostics World | Foldit is an online puzzle video game designed to fold the structures of selected proteins as perfectly as possible. Recently, the developers of the game have been partnering with companies and institutions, including Mars Incorporated and Thermo Fisher Scientific, to help target the issue of carcinogens in food.

    Dec 13, 2017
  • Advances In Lateral Flow Technology: Addressing The Limitations Of Traditional Conjugate Blocking

    Diagnostics World Contributed Commentary | Lateral flow immunoassays are simple yet powerful diagnostic tools, offering user-friendly, reliable, and low-cost testing. The goal now is to make the technology increase in signal intensity to produce less ambiguous results.

    Dec 12, 2017
  • Sarah Cannon Joins Early Breast Cancer Detection Study

    Diagnostics World Brief | Sarah Cannon announced that several of its affiliated programs will participate in a new study, called STRIVE, which focuses on developing a test for early breast cancer detection.

    Dec 8, 2017
  • AI Forerunner IDx Explains How New Test Could Cut Healthcare Costs Improve Diagnosis of Eye Disease

    Healthegy | The power of Artificial Intelligence and Machine Learning looms over Medtech as a growing force that will bring change, good or bad. In this Medtech Talk Podcast, Michael Abramoff, MD, PhD, president, director and co-founder of IDx, tells how the start-up is using AI to better diagnose diabetic retinopathy. The company hopes to secure FDA approval for its IDx-DR system following the completion of clinical trials this summer.

    Dec 7, 2017
  • Quanterix Files Proposed Terms For $50 Million IPO

    Seeking Alpha | Quanterix has proposed terms for its $50 million U.S. IPO. The company plans to sell 3.34 million shares of common stock at $15.00 per share.

    Dec 6, 2017
  • Teladoc, Celmatix, ANGLE, And More: News From November 2017

    Diagnostics World | November featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Teladoc, Celmatix, ANGLE, and more.

    Dec 5, 2017
  • Vanderbilt Uses Face2Gene Suite for Undiagnosed Diseases

    Diagnostics World Brief | Vanderbilt University Medical Center announced integration of FDNA’s Face2Gene suite of applications into the Vanderbilt Center for Undiagnosed Diseases workflow to evaluate difficult-to-diagnose patients in their role as part of the National Institutes of Health (NIH) Undiagnosed Disease Network (UDN).

    Dec 4, 2017
  • FDA Approves FoundationOne CDx, CMS Agrees To Cover

    OncLive | The FDA announced that it has approved the FoundationOne CDx assay. The Centers for Medicare & Medicaid Services issued a simultaneous announcement saying the next-generation sequencing-based in vitro diagnostic test will be covered by insurance.

    Dec 1, 2017
  • Meet The Startup Revolutionizing The Lab Testing Industry

    Forbes | One of the most significant inefficiencies in our healthcare system is the inaccessibility to life-saving lab tests. EverlyWell is changing that narrative by making lab testing accessible and meaningful for consumers.

    Nov 30, 2017